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Abstract Sister chromatid separation and mitotic exit are
triggered by the anaphase-promoting complex (APC/C) which is
a multi-subunit ubiquitin ligase required for proteolytic degrada-
tion of various target proteins. Cdc20 and Cdh1 are substrate-
specific activators of the APC/C. It was previously proposed that
Cdh1 is essential for proteolysis of the yeast mitotic cyclin Clb2.
We show that Clb2 proteolysis is triggered by two different
modes during mitosis. A fraction of Clb2 is degraded during
anaphase in the absence of Cdh1. However, a second fraction of
Clb2 remains stable during anaphase and is degraded in a Cdh1-
dependent manner as cells exit from mitosis. Most of cyclin Clb3
is degraded independently of Cdh1. Our data imply that
degradation of mitotic cyclins is initiated by a Cdh1-independent
mechanism.
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1. Introduction
Proteolysis is an important mechanism for progression
through the eukaryotic cell cycle. Major cell cycle transitions
such as the initiation of DNA replication, the separation of
sister chromatids and the exit from mitosis are all dependent
on proteolytic degradation of speci¢c proteins [1,2]. Chains of
ubiquitin molecules are ligated to these target proteins which
subsequently are rapidly degraded by the 26S proteasome.
The anaphase-promoting complex (APC/C), also called cy-
closome, is an ubiquitin^protein ligase which is essential for
ubiquitin-dependent proteolysis during mitosis. This large
complex, consisting of 12 subunits in Saccharomyces cerevisi-
ae, appears to be highly conserved in all eukaryotes [3^6]. At
the metaphase to anaphase transition, the APC/C triggers
proteolytic degradation of Pds1 or Cut2 which act as ana-
phase inhibitor proteins in budding or ¢ssion yeast, respec-
tively [7,8]. Pds1 blocks the sister separating protein Esp1 and
thereby prevents the dissociation of cohesins from chromo-
somes [9^11]. Pds1 degradation, initiated by APC/C activa-
tion, liberates Esp1 which then induces the cleavage of the
cohesin subunit Scc1 and the separation of sister chromatids
[12]. Activation of the APC/C prior to anaphase onset re-
quires an additional activating subunit, the WD40 repeat pro-
tein Cdc20 or related proteins in vertebrate cells [13^16]. The
activity of the APC/CCdc20 complex is inhibited by the spindle
assembly checkpoint which is activated upon defects in the
mitotic spindle or by unattached kinetochores and thereby
prevents the separation of sister chromatids [17^20].
Cdh1 (also termed Hct1), a protein related to Cdc20, binds
to the APC/C in telophase and is needed for degradation of
the mitotic cyclin Clb2 and other proteins such as the spindle-
associated protein Ase1 and the polo-like protein kinase Cdc5
[13,21^23]. It is thought that Cdc20 and Cdh1 act as sub-
strate-speci¢c activators of the APC/C and thereby ensure
that di¡erent target proteins of the APC/C are degraded in
a proper temporal order during mitosis.
Cdc20 is an unstable protein whose abundance is tightly
regulated during the cell cycle [16]. Cdc20 instability depends
on APC/C activity, indicating that Cdc20 is also a substrate of
this ubiquitin ligase. In contrast, Cdh1 protein levels do not
signi¢cantly £uctuate during the cell cycle [24,25]. Instead, the
association of Cdh1 and APC/C is cell cycle-regulated by
phosphorylation and dephosphorylation of Cdh1. Cyclin-de-
pendent kinases (CDKs) inhibit the interaction of Cdh1 with
the APC/C [24,25], whereas the protein phosphatase Cdc14
reverses CDK-mediated phosphorylation and promotes
Cdh1 binding [25,26]. A network of additional late mitotic
proteins, including the protein kinases Cdc5 [27], Cdc15 [28],
Dbf2 and Dbf20 [29], the small GTPase Tem1 [30] and the
guanine-nucleotide exchange factor Lte1 [31] are also required
for mitotic exit. The function of these factors and their regu-
lation are poorly understood. Many of these proteins are pre-
sumably involved in the activation of Cdc14, which is seques-
tered and kept inactive in the nucleolus for most of the cell
cycle [32,33]. Cdc14 phosphatase activity not only enables
APC/CCdh1 complex formation, but also stabilizes Sic1, a
CDK inhibitor, and induces nuclear entry of Swi5, a tran-
scription factor required for e⁄cient SIC1 expression [26].
Thus, Cdc14 promotes two di¡erent pathways leading to the
inactivation of Cdk1 in late mitosis : cyclin proteolysis and
Cdk1 inhibition. Inactivation of Cdk1 enables cells to disas-
semble the mitotic spindle, to undergo cytokinesis and to es-
tablish pre-replicative complexes in preparation for a new
round of DNA replication.
Studies on the major mitotic cyclin Clb2 showed that pro-
teolysis of this cyclin is fully dependent on Cdh1 upon a
release from a telophase arrest and during a G1 arrest [22].
Previous experiments indicated that Clb2 destruction is initi-
ated already early in anaphase [34]. Here, we analyzed the role
of Cdh1 and proteins of the mitotic exit network in Clb2
proteolysis. We found that a ¢rst fraction of Clb2 is degraded
during anaphase in the absence of the substrate-speci¢c acti-
vator Cdh1, whereas proteolysis of a second fraction of Clb2
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depends on Cdh1 and late mitotic proteins such as Cdc15.
Clb3 destruction also occurred in the absence of Cdh1. We
conclude that mitotic cyclins are degraded in a biphasic man-
ner and by two di¡erent modes during mitosis.
2. Materials and methods
2.1. Yeast strains and plasmid
All yeast strains used in this study are derivatives of the S. cerevi-
siae W303 strain (MATa ade2-1 trp1-1 can1-100 leu2-3,12 his3-11,15
ura3 GAL psi+). All strains with cdh1 deletions used in this study are
derivatives of K7007 (cdh1: :HIS5, HIS5 gene from Schizosaccharo-
myces pombe), kindly provided by M. Shirayama. To con¢rm that
HIS+ segregants are indeed deleted in the CDH1 gene, the absence
of CDH1 mRNA was veri¢ed by Northern hybridization. The GAL-
CLB3-HA3 construct was previously described [35]. The GAL1-CLB1-
vN construct contains a truncated CLB1 gene under the control of the
GAL1 promoter. The truncated CLB1 gene lacking the ¢rst 120 N-
terminal amino acids was fused to the GAL1 promoter and the gene
fusion construct was cloned into the integrative plasmid YIp211 [36].
The resulting plasmid was linearized with ApaI and integrated into the
corresponding yeast strains.
2.2. Growth conditions and cell cycle arrests
Cells were grown in YEP medium (2% bactopeptone, 1% yeast
extract, 0.005% adenine sulfate) supplemented either with 2% glucose
(YEPD) or 2% ra⁄nose (YEP+Ra¡) or appropriate minimal media
[37]. Prior to cell cycle arrests, cultures were pre-grown to log phase
(OD600 0.3^0.6) at 25‡C in YEPD. When a gene was expressed from
the inducible GAL1 promoter, cells were pre-grown in YEP+Ra¡. The
GAL1 promoter was induced by the addition of galactose (2% ¢nal
concentration). To turn o¡ the GAL1 promoter, glucose was added
(2% ¢nal concentration) or cells were ¢ltered and resuspended in fresh
medium containing 2% glucose.
To arrest cells in G1-phase, yeast cultures were incubated for 2.5 h
in the presence of K-factor (5 Wg/ml ¢nal concentration). To arrest
cells with the microtubule depolymerizing drug nocodazole, cells were
incubated for 2.5^3 h in the presence of 15 Wg/ml nocodazole (added
from a 1.5 mg/ml stock solution in dimethylsulfoxide). For releasing
cells from a nocodazole block, cells were ¢ltered and washed with ¢ve
volumes of YEP medium containing 1% dimethylsulfoxide. 1% Di-
methylsulfoxide was also added to the release medium.
2.3. Immunoblot analysis
Preparation of whole cell extracts and protein immunoblot analysis
were performed as described [38]. After separation on SDS gels, pro-
teins were transferred to nitrocellulose membranes (Amersham). The
enhanced chemiluminescence detection system (ECL, Amersham) was
used to detect speci¢c proteins. Antibodies were used in 1:1000
(Clb2), 1:2000 (Cdc28), 1:10 000 (Swi6) and 1:100 (HA antibody,
12CA5) dilutions, respectively.
2.4. Other methods
RNA isolation and Northern hybridization were performed as de-
scribed [39]. Polymerase chain reaction-generated fragments of the
respective genes were radiolabelled by random primer labelling (Stra-
tagene) and used as hybridization probes. For immuno£uorescence
microscopy, cells were ¢xed in 3.7% formaldehyde and spheroplasts
were prepared as described in [40]. DAPI (4,6-diamidino-2-phenylin-
dole) staining and anti-tubulin antibodies were used for visualization
of nuclei and spindles, respectively.
3. Results
3.1. Mitotic exit mutants of S. cerevisiae arrest with reduced
Clb2 levels
To analyze Clb2 stability during anaphase, we determined
Clb2 levels in a synchronous culture of temperature-sensitive
cdc15-2 mutants released from an K-factor-induced G1 arrest.
These cells were incubated at 37‡C and therefore blocked cell
cycle progression in late anaphase/telophase. We found that
Clb2 accumulates to high levels during mitosis, but the
amount of this mitotic cyclin subsequently decreases as cells
arrest in late anaphase/telophase (Fig. 1A). These data con-
¢rm previous ¢ndings showing that Clb2 is partially degraded
in cdc15-2 mutants [34,38].
We next tested the role of several factors of the mitotic exit
network in Clb2 degradation. Clb2 levels were determined in
temperature-sensitive cdc5 (msd2-1), dbf2-2, cdc14-3, tem1-3
and cdc15-2 yeast mutants. Each of these mutants is defective
in mitotic exit and arrests at the non-permissive temperature
with elongated mitotic spindles and chromosomes segregated
to opposite poles [5,23]. These mutant strains were arrested
either in metaphase using the spindle depolymerizing drug
nocodazole or in late anaphase/telophase by a shift to the
non-permissive temperature. In each of the mutants, Clb2
levels were lower in telophase cells than in metaphase cells
(Fig. 1B). Thus, a partial decrease in Clb2 levels during ana-
phase seems to occur independently of proteins of the mitotic
exit network. In contrast, cdc20-3 and cdc23-1 mutants which
are impaired in anaphase onset contain similar amounts of
Clb2 after nocodazole treatment or after a temperature shift,
indicating that Clb2 is completely stable in these mutants.
cdc20-3 pds1 mutants are able to undergo anaphase because
the anaphase inhibitor Pds1 is absent. Instead, this double
mutant arrests in telophase [41]. To test whether cdc20-3
pds1 cells contain similar amounts of Clb2-like mitotic exit
mutants at their non-permissive temperature, protein levels
were determined in these telophase-arrested cells. We found
that cdc20-3 pds1 cells arrest with Clb2 levels similar to meta-
phase-arrested cdc20-3 cells. In contrast to other mitotic exit
mutants, Clb2 levels are not signi¢cantly decreased in telo-
phase-arrested cells lacking a functional Cdc20. Thus, Cdc20
is apparently required for the decrease of Clb2 levels during
anaphase.
Remarkably, cdc15-2 mutants lacking the CDH1 gene also
contain lower levels of Clb2 when compared to metaphase-
arrested cells. Nocodazole-arrested cdc15-2 cdh1 cells were
also shifted to 37‡C to ensure that the di¡erence between
metaphase- and telophase-arrested cells is not merely due to
the temperature shift (Fig. 1C). In comparison to telophase
cells, Clb2 remained at constantly higher levels in metaphase
cells. These data indicate that a decrease of Clb2 during ana-
phase occurs independently of the substrate-speci¢c activator
Cdh1.
3.2. Destruction box-mediated proteolysis of Clb2 is
independent of Cdh1 during anaphase
To test whether Clb2 proteolysis during anaphase occurs
independently of Cdh1, Clb2 levels were analyzed during ana-
phase in cells lacking the CDH1 gene. cdc15-2 cdh1 mutant
cells were ¢rst blocked in metaphase by nocodazole treatment.
Clb2 was transiently expressed from the GAL1 promoter and
accumulated to high levels because Clb2 is stable in these
arrested cells [42]. Cells were then released from the meta-
phase arrest and were subsequently blocked in late ana-
phase/telophase, as a consequence of the cdc15-2 mutation.
During anaphase, a large fraction of Clb2 was degraded de-
spite the cdh1 mutation, whereas a second fraction of Clb2
remained stable under these conditions (Fig. 2A). The de-
crease in Clb2 levels during anaphase was dependent on its
cyclin destruction box, because a mutant Clb2 protein lacking
its 9 amino acid destruction box, Clb2vDB [42], remained
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stable during anaphase. Furthermore, the decrease in Clb2
levels was dependent on the removal of nocodazole and there-
fore on anaphase entry, because Clb2 degradation did not
occur when nocodazole was present at all times (Fig. 2B).
These results indicate that proteolytic degradation of a large
fraction of Clb2 during anaphase is dependent on APC/C
activity, but occurs independently of Cdh1 and Cdc15. Partial
degradation of Clb2 was similar in a CDH1 wild-type strain
and a cdh1 deletion strain, indicating that Cdh1 has no im-
portant role in proteolysis of this fraction of Clb2 (Fig. 2C).
3.3. Proteolysis of a second pool of Clb2 requires Cdh1
Our ¢ndings showed that during anaphase a ¢rst pool of
Clb2 is unstable, whereas a second pool remains stable in the
absence of Cdh1 and Cdc15 function. Cdh1 was previously
shown to be essential for Clb2 degradation as cells exit from
mitosis [22]. We analyzed whether Cdh1 is exclusively needed
for proteolysis of this second fraction of Clb2. To test this,
cdc15-2 CDH1 and cdc15-2 cdh1 strains were pre-arrested in
metaphase with nocodazole. Then, Clb2 expression was tran-
siently induced and cells were subsequently released from this
arrest at 37‡C. The cdc15-2 mutation then caused these cells
to arrest in late anaphase/telophase. During the metaphase to
telophase transition, Clb2 levels were distinctly reduced inde-
pendently of Cdh1 (Fig. 3). Subsequently, cells were released
from the cdc15-2 arrest by a shift to the permissive temper-
ature. Proteolysis of the remaining Clb2 protein was depen-
dent on Cdh1, whereas no further decrease in Clb2 levels
occurred in the cdh1 mutant strain.
Taken together, degradation of the second pool of Clb2
Fig. 1. Late mitotic mutants arrest with decreased Clb2 levels. (A) cdc15-2 mutant cells (K1993) were arrested with K-factor in G1-phase for
2.5 h at 25‡C. Subsequently, cells were released by removing the pheromone and incubated at 37‡C. The synchrony of the culture was checked
by counting the number of buds and elongated spindles. Clb2 protein levels were determined by immunoblotting with antibodies against Clb2.
Swi6 protein was used as a loading control. (B) Various mutants defective in mitotic exit, cdc5 (msd2-1, K5998), dbf2-2 (K4902), cdc14-3
(K2887), tem1-3 (K5850), cdc15-2 (K1993) and a cdc15-2 cdh1 double mutant (S212) were pre-grown at 25‡C in YEPD medium. Cultures were
split and incubated for 3 h either at 25‡C in the presence of the spindle depolymerizing drug nocodazole or at 37‡C. Cultures of two mutants
defective in anaphase onset, cdc23-1 (K2531) and cdc20-3 (K7108), as well as of a cdc20-3 pds1 double mutant (K7109), were also incubated
under these conditions. Clb2 was visualized using Clb2 antibodies. Cdc28 was used as a loading control. (C) The cdc15-2 cdh1 culture was
treated as described in (B), but the nocodazole-treated culture was split after 2.5 h and incubation was continued in the presence of nocodazole
either at 25‡C for 3 h or at 37‡C for 1 and 3 h. Swi6 was used as a loading control.
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which occurs in the presence of functional Cdc15 is dependent
on Cdh1, in contrast to the initial proteolysis of Clb2 during
anaphase. These ¢ndings suggest that Clb2 is ubiquitinated
during mitosis by two di¡erent modes which are Cdh1-inde-
pendent during anaphase or Cdh1-dependent as cells exit from
mitosis.
3.4. Clb2 levels are reduced in the presence of highly active
Cdk1
Similar to a cdc15-2 mutation, the expression of non-de-
gradable mitotic cyclins blocks cells in late anaphase/telo-
phase. The presence of large amounts of cyclins and highly
active Cdk1 prevents these cells to exit from mitosis [38,43].
We analyzed the in£uence of highly active Cdk1 on Clb2
levels. For this purpose, a construct containing an N-termi-
nally truncated Clb1 cyclin expressed from the GAL1 pro-
moter was integrated into CDH1 and cdh1 strains. This
Clb1 mutant protein was apparently very stable because cells
were inviable on galactose containing plates and the addition
of galactose rapidly caused cells to arrest with elongated spin-
dles (data not shown). Cells containing the GAL1-CLB1-vN
construct were arrested either in metaphase by nocodazole
treatment or in telophase by the addition of galactose. In
the presence of stable Clb1 and highly active Cdk1, Clb2
levels were lower in telophase-arrested cells than in metaphase
cells (Fig. 4). The decrease in Clb2 protein was independent of
Cdh1, because Clb2 levels were similarly decreased in CDH1
and cdh1 strains.
Fig. 2. Clb2 degradation during anaphase occurs independently of Cdh1. (A) cdc15-2 strains, in which the endogenous CDH1 and CLB2 genes
are deleted (cdc15-2 cdh1 clb2) and which contain either a GAL-CLB2 (S283) or a GAL-CLB2vDB (CLB2 with a cyclin destruction box dele-
tion, S284) construct were pre-grown in YEP+Raf medium at 25‡C and subsequently treated with nocodazole for 2.5 h to arrest cells in meta-
phase. 2% Galactose was added to express the CLB2 or CLB2vDB genes, respectively. After 30 min, the cultures were shifted to 35‡C to inac-
tivate the Cdc15 protein and incubation in the presence of nocodazole was continued for 30 min. Then cells were ¢ltered, washed and released
from the nocodazole arrest in YEPD medium at 37‡C. The glucose medium repressed the GAL1 promoter. Samples were collected at the indi-
cated time points after the shift to YEPD medium (0 min time point). The cdc15-2 mutation caused these cells to arrest in late anaphase/telo-
phase. Clb2 and Clb2vDB levels were determined by immunoblotting using antibodies against Clb2. Cdc28 was used as a loading control. To
con¢rm that expression of CLB2 and CLB2vDB was turned o¡ in glucose medium, RNA levels were analyzed by Northern hybridization.
CMD1 mRNA (calmodulin mRNA) was used as a loading control. To con¢rm that cells released from the nocodazole-induced metaphase ar-
rest, the appearance of mitotic spindles was veri¢ed by immuno£uorescence microscopy using antibodies against tubulin. In both strains, no tu-
bulin staining was visible when cells were treated with nocodazole. Upon removal of the nocodazole, spindles appeared in more than 80% of
the cells between the 20 min and 40 min time points after the release (data not shown). (B) The cdc15-2 cdh1 clb2 GAL-CLB2 strain (S283)
was arrested in metaphase with nocodazole and CLB2 was expressed as described in (A). Prior to the release, the culture was split; the ¢rst
half was incubated in YEPD medium containing nocodazole and the second half was incubated without nocodazole. (C) Strain S283 and an
isogenic CDH1 strain (S80) were arrested in metaphase with nocodazole. CLB2 expression was transiently induced by galactose addition and
cells were released from the nocodazole arrest as described in (A).
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Thus, highly active Cdk1 apparently prevents proteolysis of
the second pool of Clb2, which is Cdh1-dependent, but does
not a¡ect the Cdh1-independent mode of Clb2 degradation.
3.5. Most of Clb3 is degraded independently of Cdh1
It was previously shown that the B-type cyclin Clb5, an S-
phase cyclin, is fully unstable during anaphase [34] and is
destroyed exclusively by the APC/CCdc20 [44]. To analyze pro-
teolytic degradation of another mitotic cyclin, we determined
the stability of cyclin Clb3 during anaphase. Previous experi-
ments implied that degradation of this mitotic cyclin may be
initiated by APC/CCdc20 [45].
Cells containing a GAL1-CLB3 construct were released
from a nocodazole arrest under similar conditions as in the
experiments described for Clb2 (Fig. 2B). Analysis of Clb3
levels revealed that most of this cyclin was degraded during
anaphase in the absence of Cdh1 and only a small fraction of
Clb3 appeared to be stable in cdc15-2 cells (Fig. 5). Thus,
proteolysis of most of Clb3 protein occurs independently of
Cdh1 and Cdc15 during anaphase.
4. Discussion
4.1. The regulation of cyclin proteolysis during mitosis
Precise regulation of the proteolytic destruction of di¡erent
target proteins is a prerequisite to ensure a proper order of
mitotic events. The anaphase inhibitor Pds1 and mitotic cy-
clins are apparently the most important targets of the APC/C
during mitosis in yeast [6,46]. Pds1 blocks sister chromatid
separation by keeping separins inactive, whereas mitotic cy-
clins maintain CDK activity and prevent mitotic exit. It is
crucial for the eukaryotic cell cycle that sister chromatid sep-
aration is always triggered earlier than the exit from mitosis.
It is thought that the APC/C activators Cdc20 and Cdh1
are the major factors controlling ubiquitination of di¡erent
substrates by the APC/C [13]. Cdc20 is essential for proteol-
ysis of Pds1, whereas Cdh1 is needed for cyclin proteolysis as
cells exit from mitosis. The APC/CCdc20 complex is activated
at metaphase, but Cdh1’s association with the APC/C is
blocked by Cdk1 activity until mitotic exit proteins such as
Cdc14 and Cdc15 are activated during telophase. Thus,
Cdc20-mediated activation of the APC/C always precedes
Cdh1’s activation during mitosis.
It is still unclear how the WD40 proteins Cdc20 and Cdh1
confer substrate-speci¢c ubiquitination. The most simple
model would propose that Cdc20 binds and targets Pds1 to
the APC/C, but does not a¡ect Clb2. Only the association of
Cdh1 with the APC/C may then allow Clb2 recognition and
ubiquitination.
Fig. 3. Degradation of a second fraction of Clb2 is dependent on
Cdh1. Strains cdc15-2 CDH1 clb2 GAL-CLB2 (S80) and cdc15-2
cdh1 clb2 GAL-CLB2 (S283) were arrested with nocodazole as de-
scribed in Fig. 2A. CLB2 was expressed by galactose addition (Noc
sample) and cells were released in YEPD medium at 37‡C. After 2 h
at 37‡C, an appropriate amount of cold YEPD medium was added
to shift the temperature to 25‡C, a permissive temperature for
cdc15-2 mutants. Samples were collected at the indicated time points
after incubation at 25‡C.
Fig. 4. Non-destructible cyclins do not inhibit Clb2 degradation
during anaphase. A wild-type CDH1 strain (S300) and a cdh1
mutant strain (S316), both containing a GAL-CLB1-vN construct
(expressing a truncated Clb1 protein lacking the N-terminal 120
amino acids including the cyclin destruction box) were pre-grown in
YEP+Raf at 30‡C. Cultures were split and either nocodazole or ga-
lactose was added. Therefore, cells arrested either in metaphase or
telophase, respectively, which was con¢rmed by immuno£uorescence
microscopy (data not shown). After 2.5 h, galactose was also added
to the nocodazole-arrested culture to con¢rm that expression of
CLB1-vN did not a¡ect Clb2 levels in metaphase-arrested cells.
Samples were collected at the indicated time points after galactose
addition. Clb2 protein levels were determined by immunoblotting,
using Cdc28 as a loading control.
Fig. 5. Most of the mitotic cyclin Clb3 is degraded independently of
Cdh1. cdc15-2 cdh1 GAL-CLB3-HA3 (S315) cells were treated with
nocodazole to arrest them in metaphase as described in Fig. 2A.
Galactose was added to express the CLB3 gene and cells were incu-
bated for 30 min at 25‡C. Subsequently, cells were shifted to 35‡C
and incubated for another 30 min. After ¢ltering and washing, the
cultures were split in two halves, which were incubated in YEPD
medium at 37‡C either in the presence or absence of nocodazole.
Samples were collected at the indicated time points after ¢ltration.
Epitope-tagged Clb3 protein was detected with antibodies against
HA (12CA5 antibodies). Clb2 was detected using Clb2 antibodies.
Cdc28 was used as a loading control.
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We have shown here that this model is unlikely and that
more complex processes are involved in the regulation of cy-
clin destruction. We found that proteolysis of mitotic cyclins
is not initiated by Cdh1-mediated activation of the APC/C.
Instead, Clb2 and Clb3 destruction is initiated in the absence
of Cdh1 and a fraction of these mitotic cyclins is degraded
during anaphase. Cdh1-independent proteolytic degradation is
most likely mediated by the APC/C because degradation is
dependent on the cyclin destruction box and on entry into
anaphase. The pool of Clb2 which remains stable throughout
anaphase is degraded prior to the mitotic exit by a mechanism
which is fully dependent on Cdh1.
Furthermore, we found that many mutants defective in mi-
totic exit contain lower Clb2 levels compared to metaphase
cells. Similarly, cells arrested in telophase due to the expres-
sion of a truncated, non-degradable Clb1 cyclin also arrest
with decreased Clb2 levels. Thus, neither the absence of
Cdh1 and mitotic exit proteins nor highly active CDKs inhibit
partial Clb2 proteolysis during anaphase, but prevent the
completion of cyclin proteolysis.
We conclude that Clb2 is degraded by two di¡erent modes
during mitosis. Initially, Clb2 proteolysis occurs during ana-
phase independently of Cdh1 and mitotic exit proteins such as
Cdc15. Later, when cells exit from mitosis, Clb2 degradation
occurs in a Cdh1-dependent manner (Fig. 6).
Recent data showed that proteolysis of mitotic cyclins is
activated early in anaphase also in other organisms. Degrada-
tion of human cyclin B1 was found to be regulated temporally
and spatially [47]. Cyclin B1 disappeared from chromosomes
and spindle poles immediately after the spindle checkpoint
had been inactivated. A localized disappearance of cyclin B
was also observed in Drosophila cells [48]. Thus, mitotic cyclin
destruction seems to be initiated at de¢ned locations, mainly
at the spindle poles, in these cells.
Similarly, Clb2 proteolysis in yeast might be regulated by its
subcellular localization. Some Clb2 molecules might get ubiq-
uitinated by the APC/C even if Cdh1 is not present, whereas a
second pool of Clb2 molecules might be present at speci¢c
locations in the cell where their access to the APC/C is strictly
dependent on Cdh1. Alternatively, the access of Clb2 to the
APC/C might be di¡erentially regulated by post-translational
modi¢cations of some Clb2 molecules.
4.2. The role of Cdc20 in cyclin proteolysis
Another important question is how a pool of mitotic cyclins
may be ubiquitinated by the APC/C during anaphase in the
absence of the substrate-speci¢c activator Cdh1. The observa-
tion that cdc20-3 and cdc20-3 pds1 cells arrest at their restric-
tive temperature with high levels of Clb2 indicates that Cdc20
is required to initiate Clb2 proteolysis (Fig. 1B; [16,44]).
Cdc20 may directly act as a substrate-speci¢c activator of
Clb2 ubiquitination during early anaphase or, alternatively,
APC/CCdc20-mediated proteolysis may indirectly activate a
pathway leading to Clb2 proteolysis. It was earlier shown
that in vitro ubiquitination of mitotic cyclins is fully depen-
dent on Cdh1 in G1-arrested yeast cells [24]. Assuming that
proteolysis of a fraction of Clb2 is directly dependent on
Cdc20, then the failure to detect ubiquitination of mitotic
cyclins in cdh1 G1 extracts might be due to the absence of
su⁄cient Cdc20 protein in G1 cells [16]. Ubiquitination assays
using mammalian cell extracts demonstrated that APC/CCdc20
complexes ubiquitinate mitotic cyclins in vitro [14,15]. Yeast
Cdc20 may also target a pool of mitotic cyclins for ubiquiti-
nation by the APC/C. Indeed, Alexandru et al. [45] provided
evidence that Clb3 is destroyed during anaphase by the APC/
CCdc20, similarly as the S-phase cyclin Clb5 [44]. However,
APC/CCdc20 is not su⁄cient to trigger complete mitotic cyclin
destruction in the absence of Cdh1.
4.3. Cyclin proteolysis and mitotic exit
What might be the purpose of biphasic Clb2 degradation
during mitosis? Keeping Cdk1 at least partially active
Fig. 6. Model for a biphasic mode of mitotic cyclin degradation during mitosis. At the metaphase to anaphase transition, APC/CCdc20 may not
only ubiquitinate the anaphase inhibitor Pds1 (and Clb5) but also a fraction of mitotic cyclins such as Clb2 and Clb3. This process occurs in-
dependently of Cdh1 and late mitotic proteins. A second fraction of Clb2 remains protected from the proteolytic machinery during anaphase.
Ubiquitination of these cyclin proteins is dependent on Cdh1. Late mitotic proteins such as Cdc15 are apparently involved in the liberation of
Cdc14 phosphatase which is kept inactive in the nucleolus until late mitotic proteins are activated in telophase.
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throughout anaphase is needed to prevent cytokinesis and
DNA re-replication prior to the completion of chromosome
segregation. On the other hand, a partial decrease in mitotic
cyclin levels and Cdk1 activity might be a prerequisite for the
proper activation of the mitotic exit network. Highly active
Cdk1 may inhibit the activity of these proteins required for
mitotic exit. Indeed, elevated Clb2 levels have a drastic e¡ect
on many mitotic exit mutants even under permissive condi-
tions [23].
Highly active Cdk1 might preliminarily interfere with
Cdc14 phosphatase activity. Release of Cdc14 from the nucle-
olus is not a¡ected by the expression of high levels of non-
degradable cyclins [33], but the activity of Cdc14 might be
insu⁄cient to reverse phosphorylation of a fully active
Cdk1. Then, Cdc14 phosphatase, upon release from the nu-
cleolus, could only win the competition against Cdk1 if mi-
totic cyclins are partially destroyed, but never in the presence
of very active kinase. Such a mechanism may help to ensure
that Cdc14-dependent dephosphorylation of Cdh1, Sic1 and
Swi5 never occurs before sister chromatid separation, which
takes place in the presence of highly active Cdk1 [38,49].
In conclusion, degradation of a fraction of Clb2 and other
mitotic cyclins might be necessary to activate the pathway
leading to completion of Clb2 proteolysis, Cdk1 inactivation
and cytokinesis.
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